Oxymetazoline for Rosacea: Four REVEAL Trial Checks

A cream that fades background color and a medicine for rosacea bumps answer different questions. The American Academy of Dermatology¹ describes oxymetazoline cream as a temporary treatment for persistent facial color: its strongest effect generally occurs three to six hours after application, then the color gradually returns. That makes the hour of assessment part of the answer.¹

Check the treatment target

REVEAL randomized 885 adults with moderate-to-severe persistent rosacea redness: 1% oxymetazoline cream versus vehicle daily for 29 days. More than three inflammatory facial lesions excluded participation. Participants were predominantly White women, without menopause-specific selection.²³

Before discussing this prescription, identify which feature you want treated: color that stays between flushes, brief flushing episodes, bumps, visible vessels or eye symptoms. The academy describes separate treatment options for those features. A prescription intended for persistent color should not become a promise to treat every feature on that list.¹

Read the timed response

Success required improvement of at least two grades on both clinician and patient redness scales. At hour 12 on day 29, rates were 14.8% versus 6.0% and 12.3% versus 6.1% in the two trials. These are time-specific responses, not all-day clearance.³

For a prescription review, bring the time you applied the cream, the time you assessed its effect and any discomfort you noticed. A morning photograph and an evening photograph answer different questions when a treatment’s effect wears off. The academy’s description of temporary benefit is a reason to discuss that schedule explicitly.¹

Examine missing observations

Twenty-three active and ten vehicle participants discontinued. Primary analyses used 20 imputed datasets; FDA’s³ extreme scenario, counting missing active observations as failures and vehicle observations as successes, made the second trial’s result nonsignificant. Ordered secondary testing also prevented a confirmatory one-hour-onset claim. Allergan sponsored; authors included employees.²³

Ask what would count as enough improvement for you to continue the prescription, and when you would report worsening color, stinging or other symptoms. Agreeing on those observations before starting makes the follow-up more specific than asking whether the cream “worked.”

Review prescription precautions

The current US Rhofade instructions specify a pea-sized amount of 1% cream once daily over the face, avoiding eyes and lips. Wash hands afterward; do not apply to irritated skin or open wounds. A nasal spray containing the same ingredient is not the studied cream.⁴

Review cardiovascular disease, blood-pressure problems, faintness on standing, vascular insufficiency and narrow-angle glaucoma with the prescriber. The label also cautions about medicines including blood-pressure treatments, cardiac glycosides, alpha-1 blockers and monoamine oxidase inhibitors. It lists application-site dermatitis, worsening inflammatory lesions, itching, redness and pain among common adverse reactions.⁴

Seek immediate medical care if the cardiovascular or vascular conditions described in the warnings worsen, or symptoms of acute angle-closure glaucoma develop. Get medical help immediately after swallowing the cream. Pregnancy and breastfeeding need a discussion because the available human data cannot establish safety.⁴

Our rosacea prescription comparison explains the broader distinction between treatments for bumps, background redness and eye symptoms.

Skin, Head to Toe develops that feature-based description in “Describe Your Own Face” and “Triggers and What Helps.” Its Skin Log includes color, warmth and stinging. Use those details when preparing the prescription review, with the application and assessment times written alongside them.